Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth

NCT00120588 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Preterm Birth
Periventricular Leukomalacia
Brain Ischemia
Intracranial Hemorrhages

Interventions

DRUG: magnesium

Sponsor

University Hospital, Rouen

Collaborators

[object Object]